295 related articles for article (PubMed ID: 22105854)
1. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.
Santoro N; Zhang CK; Zhao H; Pakstis AJ; Kim G; Kursawe R; Dykas DJ; Bale AE; Giannini C; Pierpont B; Shaw MM; Groop L; Caprio S
Hepatology; 2012 Mar; 55(3):781-9. PubMed ID: 22105854
[TBL] [Abstract][Full Text] [Related]
2. The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants.
Santoro N; Feldstein AE; Enoksson E; Pierpont B; Kursawe R; Kim G; Caprio S
Diabetes Care; 2013 May; 36(5):1353-60. PubMed ID: 23275357
[TBL] [Abstract][Full Text] [Related]
3. Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey.
Hernaez R; McLean J; Lazo M; Brancati FL; Hirschhorn JN; Borecki IB; Harris TB; ; Nguyen T; Kamel IR; Bonekamp S; Eberhardt MS; Clark JM; Kao WH; Speliotes EK
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1183-1190.e2. PubMed ID: 23416328
[TBL] [Abstract][Full Text] [Related]
4. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.
Palmer ND; Musani SK; Yerges-Armstrong LM; Feitosa MF; Bielak LF; Hernaez R; Kahali B; Carr JJ; Harris TB; Jhun MA; Kardia SL; Langefeld CD; Mosley TH; Norris JM; Smith AV; Taylor HA; Wagenknecht LE; Liu J; Borecki IB; Peyser PA; Speliotes EK
Hepatology; 2013 Sep; 58(3):966-75. PubMed ID: 23564467
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
Lin YC; Chang PF; Chang MH; Ni YH
Am J Clin Nutr; 2014 Apr; 99(4):869-74. PubMed ID: 24477042
[TBL] [Abstract][Full Text] [Related]
6. Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.
Goffredo M; Caprio S; Feldstein AE; D'Adamo E; Shaw MM; Pierpont B; Savoye M; Zhao H; Bale AE; Santoro N
Hepatology; 2016 Jan; 63(1):117-25. PubMed ID: 26457389
[TBL] [Abstract][Full Text] [Related]
7. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.
Santoro N; Kursawe R; D'Adamo E; Dykas DJ; Zhang CK; Bale AE; Calí AM; Narayan D; Shaw MM; Pierpont B; Savoye M; Lartaud D; Eldrich S; Cushman SW; Zhao H; Shulman GI; Caprio S
Hepatology; 2010 Oct; 52(4):1281-90. PubMed ID: 20803499
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
Hyysalo J; Stojkovic I; Kotronen A; Hakkarainen A; Sevastianova K; Makkonen J; Lundbom N; Rissanen A; Krauss RM; Melander O; Orho-Melander M; Yki-Järvinen H
J Gastroenterol Hepatol; 2012 May; 27(5):951-6. PubMed ID: 22141340
[TBL] [Abstract][Full Text] [Related]
9. The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth.
Umano GR; Caprio S; Di Sessa A; Chalasani N; Dykas DJ; Pierpont B; Bale AE; Santoro N
Am J Gastroenterol; 2018 Mar; 113(3):376-383. PubMed ID: 29485130
[TBL] [Abstract][Full Text] [Related]
10. Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus.
Cox AJ; Wing MR; Carr JJ; Hightower RC; Smith SC; Xu J; Wagenknecht LE; Bowden DW; Freedman BI
Diabetes Metab; 2011 Nov; 37(5):452-5. PubMed ID: 21665509
[TBL] [Abstract][Full Text] [Related]
11. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake.
Santoro N; Savoye M; Kim G; Marotto K; Shaw MM; Pierpont B; Caprio S
PLoS One; 2012; 7(5):e37827. PubMed ID: 22629460
[TBL] [Abstract][Full Text] [Related]
12. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.
Wagenknecht LE; Palmer ND; Bowden DW; Rotter JI; Norris JM; Ziegler J; Chen YD; Haffner S; Scherzinger A; Langefeld CD
Liver Int; 2011 Mar; 31(3):412-6. PubMed ID: 21281435
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphisms.
Valenti L; Alisi A; Nobili V
Hepatology; 2012 Mar; 55(3):661-3. PubMed ID: 22281838
[No Abstract] [Full Text] [Related]
14. Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings From a Multiethnic Cohort.
Tricò D; Caprio S; Rosaria Umano G; Pierpont B; Nouws J; Galderisi A; Kim G; Mata MM; Santoro N
Hepatology; 2018 Oct; 68(4):1376-1390. PubMed ID: 29665034
[TBL] [Abstract][Full Text] [Related]
15. Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.
Petta S; Miele L; Bugianesi E; Cammà C; Rosso C; Boccia S; Cabibi D; Di Marco V; Grimaudo S; Grieco A; Pipitone RM; Marchesini G; Craxì A
PLoS One; 2014; 9(2):e87523. PubMed ID: 24498332
[TBL] [Abstract][Full Text] [Related]
16. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
Zhang RN; Zheng RD; Mi YQ; Zhou D; Shen F; Chen GY; Zhu CY; Pan Q; Fan JG
Dig Dis Sci; 2016 Aug; 61(8):2284-2293. PubMed ID: 27059980
[TBL] [Abstract][Full Text] [Related]
17. Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease.
Hudert CA; Selinski S; Rudolph B; Bläker H; Loddenkemper C; Thielhorn R; Berndt N; Golka K; Cadenas C; Reinders J; Henning S; Bufler P; Jansen PLM; Holzhütter HG; Meierhofer D; Hengstler JG; Wiegand S
Liver Int; 2019 Mar; 39(3):540-556. PubMed ID: 30444569
[TBL] [Abstract][Full Text] [Related]
18. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents.
Zusi C; Mantovani A; Olivieri F; Morandi A; Corradi M; Miraglia Del Giudice E; Dauriz M; Valenti L; Byrne CD; Targher G; Maffeis C
Dig Liver Dis; 2019 Nov; 51(11):1586-1592. PubMed ID: 31255630
[TBL] [Abstract][Full Text] [Related]
19. A genetic risk score is associated with hepatic triglyceride content and non-alcoholic steatohepatitis in Mexicans with morbid obesity.
León-Mimila P; Vega-Badillo J; Gutiérrez-Vidal R; Villamil-Ramírez H; Villareal-Molina T; Larrieta-Carrasco E; López-Contreras BE; Kauffer LR; Maldonado-Pintado DG; Méndez-Sánchez N; Tovar AR; Hernández-Pando R; Velázquez-Cruz R; Campos-Pérez F; Aguilar-Salinas CA; Canizales-Quinteros S
Exp Mol Pathol; 2015 Apr; 98(2):178-83. PubMed ID: 25597287
[TBL] [Abstract][Full Text] [Related]
20. A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese: A population-based study.
Yang H; Chen G; Song C; Li D; Ma Q; Chen G; Li X
Medicine (Baltimore); 2018 Mar; 97(13):e0272. PubMed ID: 29595690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
